Showing 237 Results
Distributed data network drug safety analyses are difficult to interpret in the face of heterogeneity, or individual treatment effects.
The concept of heterogeneity is explained and further explored via four articles published in the June 2014 issue of the Journal of Managed Care & Specialty Pharmacy: The Good, the Bad, and the…
Although researchers and health care providers widely recognize that individuals with stage IV prostate cancer react differently to treatments, the factors that impact treatment outcomes, including…
This 7-page brochure provides a snapshot of NPC's mission, strategic approach, recent research and leadership.
The National Pharmaceutical Council conducted its third annual survey of key health care stakeholders. The purpose was to set a baseline for where key stakeholders believe we are today on comparative…